help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, X.
Right arrow Articles by Gudas, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, X.
Right arrow Articles by Gudas, L. J.
Endocrinology Vol. 142, No. 3 1024-1032
Copyright © 2001 by The Endocrine Society


ARTICLES

Follicle-Stimulating Hormone and Leukemia Inhibitory Factor Regulate Sertoli Cell Retinol Metabolism1

Xiaojia Guo, Patricia L. Morris and Lorraine J. Gudas

Department of Pharmacology, Weill Medical College of Cornell University (X.G., L.J.G.); The Center for Biomedical Research, The Population Council (P.L.M.); and Rockefeller University (P.L.M.), New York, New York 10021

Address all correspondence and requests for reprints to: Dr. Lorraine J. Gudas, Department of Pharmacology, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021. E-mail: ljgudas{at}mail.med.cornell.edu

Sertoli cells, the somatic epithelial cells of the seminiferous tubules, provide both structural and biochemical support for developing male germ cells. The Sertoli cells are targets of retinoid action in the testis. We have found that FSH, (Bu)2cAMP, and leukemia inhibitory factor elicit substantial changes in the metabolism of [3H]retinol (vitamin A) in primary cultures of purified rat Sertoli cells. Addition of (Bu)2cAMP for 2 h or FSH for 6 h results in a 3-fold increase in the metabolism of [3H]retinol to [3H]retinoic acid ([3H]RA); the esterification of [3H]retinol to [3H]retinyl esters, especially [3H]retinyl palmitate, is also increased by approximately 5-fold. The addition of 1 µM all-trans-RA also elicits changes in [3H]retinol metabolism, but in this case the metabolism of [3H]retinol to [3H]RA is inhibited, whereas the metabolism of [3H]retinol to [3H]retinyl esters is increased by over 50-fold. Leukemia inhibitory factor increases the esterification of [3H]retinol by 2- to 3-fold. FSH leads to a reduction in the level of cellular retinol binding protein I transcripts, whereas RA increases the cellular retinol binding protein I messenger RNA level by about 2-fold at approximately 24 h. Levels of AHD-2 (aldehyde dehydrogenase-2) and RALDH-2 (retinaldehyde dehydrogenase-2) messenger RNAs, which encode enzymes that convert [3H]retinaldehyde to [3H]RA, are increased by about 2-fold by FSH, whereas no change in CYP26 (RA hydroxylase) expression is seen. Our results suggest that one function of FSH (and/or (Bu)2cAMP) in Sertoli cells is to increase the metabolism of retinol to the biologically active metabolite RA and to retinyl esters.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society